CClinicalTrials.gg
WithdrawnNCT01971541GROWUpdated Jul 2, 2014

Groups for Regaining Our Wellbeing (GROW)

A Phase 2/3 interventional study of Mindfulness-Based Stress Reduction and Cognitive Processing Therapy in Posttraumatic Stress Disorder and Depression, sponsored by US Department of Veterans Affairs. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-07-02.

Sponsored by US Department of Veterans Affairs · Phase 2/3, Interventional, and Treatment

Phase
Phase 2/3
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The proposed study is a randomized, controlled trial that will assess whether two group interventions for PTSD - Mindfulness-Based Stress Reduction (MBSR) and Cognitive Processing Therapy-Cognitive only (CPT-C) result in similar improvements in PTSD symptoms and health-related quality of life (QOL). One hundred fifty-two Veterans with PTSD will be randomized to MBSR (n = 76) or CPT-C (n = 76). Comprehensive assessments will take place post-treatment and 3 months later.

Read the detailed description

The proposed study is a randomized, controlled non-inferiority trial that will assess whether Mindfulness-Based Stress Reduction (MBSR) and Cognitive Processing Therapy-Cognitive only (CPT-C) result in equivalent improvement in both PTSD symptoms and health-related quality of life (QOL). PTSD symptoms will be measured by the Clinician Administered PTSD Scale - CAPS and health-related QOL will be measured by the SF-36V Mental Component Summary Score - MCS. In an exploratory aim, we will also assess whether there is a clinically meaningful response as defined by improvement in both PTSD symptoms and QOL (defined as a reliable change of 12 points on the CAPS and 10 points on the MCS, respectively, according to the reliable change index).7, 8 One hundred fifty-two Veterans with PTSD will be randomized to MBSR (n = 76) or CPT-C (n = 76). Comprehensive assessments will take place post-treatment and 3 months later. Qualitative analysis of brief semi-structured interview data will be used to identify previously unrecognized factors pertaining to participation, adherence and response to treatment, spirituality and religion as treatment moderators, and to identify common themes that may inform treatment retention efforts for both MBSR and CPT-C. In addition, potential moderators of change in PTSD symptoms and QOL for MBSR and CPT-C will be identified.

02

Conditions studied

  • Posttraumatic Stress Disorder
  • Depression

Keywords

  • mindfulness
  • behavior therapies, cognitive
  • posttraumatic stress disorder
  • group therapy
03

In context

Stress Disorders, Traumatic

1,147 studies on the registry are indexed under Stress Disorders, Traumatic; 108 are open to participants now.

Browse Stress Disorders, Traumatic studies →

Lead sponsor

US Department of Veterans Affairs is the lead sponsor of 658 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Veterans with current DSM-V diagnosis of PTSD

Exclusion criteria

Exclusion Criteria:

  • Current substance use disorder other than alcohol,
  • Alcohol involvement that poses a safety concern or is associated with inability to follow through on assessments and class attendance as evinced by past month appointment attendance record in CPRS,
  • Suicidal or homicidal ideation with intent or plan within the past 3 months,
  • Self harm in the past 3 months,
  • A psychotic disorder,
  • Uncontrolled bipolar disorder,
  • Chart diagnoses of borderline personality disorder or antisocial personality disorder,
  • In-patient admission for psychiatric reasons within the past month,
  • Prior participation in MBSR or CPT.
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Mindfulness-Based Stress Reduction (MBSR)

    An 8-week program designed to teach mindfulness skills

    Behavioral: Mindfulness-Based Stress Reduction

  • Active comparator
    Cognitive Processing Therapy

    A group-administered PTSD treatment program.

    Behavioral: Cognitive Processing Therapy

Interventions

  • BehavioralMindfulness-Based Stress Reduction

    A validated 8-week group program that teaches mindfulness meditation

    Also known as: MBSR

  • BehavioralCognitive Processing Therapy

    A validated group program of PTSD treatment, which focuses on cognitive processing.

    Also known as: CPT

06

What researchers measure

Primary outcomes

  1. PTSD symptoms

    Clinician-administered PTSD Scale (CAPS)

    Time frame: 3 months follow-up

Secondary outcomes

  1. Health-related Quality of Life

    SF-36V

    Time frame: 3 months follow-up

07

Study locations

1 site
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA
    Seattle, Washington 98108, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01971541
Lead sponsor
US Department of Veterans Affairs
Responsible party
Sponsor
First posted
Oct 29, 2013
Start date
Apr 2014
Primary completion
Mar 2017 (estimated)
Completion
Mar 2017 (estimated)
Last update
Jul 2, 2014

Study contacts

David J. Kearney, MD
principal investigator · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion